Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Ovarian Neoplasms 2Lung Neoplasms 2Carcinoma, Ovarian Epithelial 2Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Oligodendroglioma 1Mouth Neoplasms 1Liver Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Central Nervous System Neoplasms 1Carcinoma, Hepatocellular 1Carcinoma in Situ 1Breast Neoplasms 1Brain Neoplasms 1Astrocytoma 1Adenocarcinoma, Bronchiolo-Alveolar 1

Interventions

pembrolizumab 6Cisplatin 6Magnetic Resonance Spectroscopy 5Specimen Handling 4Radiotherapy 3Radiation 3Nivolumab 3Fluorouracil 3Biopsy 3Surveys and Questionnaires 2Radiosurgery 2Paclitaxel 2Chemoradiotherapy 2Cetuximab 22-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 2zimberelimab 1toripalimab 1temsirolimus 1peposertib 1nabiximols 1motexafin gadolinium 1mogamulizumab 1ipatasertib 1dl1520 1camrelizumab 1brodalumab 1belinostat 1apatinib 1advexin 1Valproic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Mouth Neoplasms × advexin × Clear all
NCT00410865 2011-12-07

Wild Type p53 Adenovirus for Oral Premalignancies

M.D. Anderson Cancer Center

Phase 1 Terminated
4 enrolled
Head & Neck

Carcinoma in Situ, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡